Prescient Therapeutics, Ltd.
7 clinical trials · Sponsor
◉ Watch Prescient Therapeutics, Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL (NCT06854653) | Prescient Therapeutics, Ltd. | 2025-03-28 |
| Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort (NCT03900442) | Prescient Therapeutics, Ltd. | 2019-09-01 |
Track Prescient Therapeutics, Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.